PubMed

The synergistic effect of miglitol plus metformin combination therapy in the treatment of type 2 diabetes.

Chiasson JL, Naditch L; Miglitol Canadian University Investigator Group.

Diabetes Care. 2001 Jun;24(6):989-94.PMID: 11375358 [PubMed - indexed for MEDLINE]Related articlesFree article

Miglitol combined with metformin improves glycaemic control in type 2 diabetes.

Van Gaal L, Maislos M, Schernthaner G, Rybka J, Segal P.

Diabetes Obes Metab. 2001 Oct;3(5):326-31.PMID: 11703422 [PubMed - indexed for MEDLINE]Related articles

Improved glycaemic control with miglitol in inadequately-controlled type 2 diabetics.

Standl E, Schernthaner G, Rybka J, Hanefeld M, Raptis SA, Naditch L.

Diabetes Res Clin Pract. 2001 Mar;51(3):205-13.PMID: 11269893 [PubMed - indexed for MEDLINE]Related articles

The efficacy and safety of miglitol therapy compared with glibenclamide in patients with NIDDM inadequately controlled by diet alone.

Segal P, Feig PU, Schernthaner G, Ratzmann KP, Rybka J, Petzinna D, Berlin C.

Diabetes Care. 1997 May;20(5):687-91.PMID: 9135927 [PubMed - indexed for MEDLINE]Related articles

Chronic treatment of African-American type 2 diabetic patients with alpha-glucosidase inhibition.

Johnston PS, Feig PU, Coniff RF, Krol A, Kelley DE, Mooradian AD.

Diabetes Care. 1998 Mar;21(3):416-22.PMID: 9540025 [PubMed - indexed for MEDLINE]Related articlesFree article

Long-term titrated-dose alpha-glucosidase inhibition in non-insulin-requiring Hispanic NIDDM patients.

Johnston PS, Feig PU, Coniff RF, Krol A, Davidson JA, Haffner SM.

Diabetes Care. 1998 Mar;21(3):409-15.PMID: 9540024 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of the carbohydrase inhibitor miglitol in sulfonylurea-treated NIDDM patients.

Johnston PS, Coniff RF, Hoogwerf BJ, Santiago JV, Pi-Sunyer FX, Krol A.

Diabetes Care. 1994 Jan;17(1):20-9.PMID: 8112185 [PubMed - indexed for MEDLINE]Related articles

Advantages of alpha-glucosidase inhibition as monotherapy in elderly type 2 diabetic patients.

Johnston PS, Lebovitz HE, Coniff RF, Simonson DC, Raskin P, Munera CL.

J Clin Endocrinol Metab. 1998 May;83(5):1515-22.PMID: 9589648 [PubMed - indexed for MEDLINE]Related articlesFree article

Dose-dependent efficacy of miglitol, an alpha-glucosidase inhibitor, in type 2 diabetic patients on diet alone: results of a 24-week double-blind placebo-controlled study.

Drent ML, Tollefsen AT, van Heusden FH, Hoenderdos EB, Jonker JJ, van der Veen EA.

Diabetes Nutr Metab. 2002 Jun;15(3):152-9.PMID: 12173729 [PubMed - indexed for MEDLINE]Related articles

Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.

Roberts VL, Stewart J, Issa M, Lake B, Melis R.

Clin Ther. 2005 Oct;27(10):1535-47.PMID: 16330290 [PubMed - indexed for MEDLINE]Related articles

Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

Comparison of extended-release metformin in combination with a sulfonylurea (glyburide) to sulfonylurea monotherapy in adult patients with type 2 diabetes: a multicenter, double-blind, randomized, controlled, phase III study.

Lewin A, Lipetz R, Wu J, Schwartz S.

Clin Ther. 2007 May;29(5):844-55.PMID: 17697903 [PubMed - indexed for MEDLINE]Related articles

Miglitol: a review of its therapeutic potential in type 2 diabetes mellitus.

Scott LJ, Spencer CM.

Drugs. 2000 Mar;59(3):521-49. Review.PMID: 10776834 [PubMed - indexed for MEDLINE]Related articles

Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes.

Horton ES, Clinkingbeard C, Gatlin M, Foley J, Mallows S, Shen S.

Diabetes Care. 2000 Nov;23(11):1660-5.PMID: 11092289 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and safety profile of glimepiride in Mexican American Patients with type 2 diabetes mellitus: a randomized, placebo-controlled study.

Luis Bautista J, Bugos C, Dirnberger G, Atherton T.

Clin Ther. 2003 Jan;25(1):194-209.PMID: 12637120 [PubMed - indexed for MEDLINE]Related articles

Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study.

Moretto TJ, Milton DR, Ridge TD, Macconell LA, Okerson T, Wolka AM, Brodows RG.

Clin Ther. 2008 Aug;30(8):1448-60. Erratum in: Clin Ther. 2008 Oct;30(10):1937. PMID: 18803987 [PubMed - indexed for MEDLINE]Related articles

Rosiglitazone/metformin fixed-dose combination compared with uptitrated metformin alone in type 2 diabetes mellitus: a 24-week, multicenter, randomized, double-blind, parallel-group study.

Bailey CJ, Bagdonas A, Rubes J, McMorn SO, Donaldson J, Biswas N, Stewart MW.

Clin Ther. 2005 Oct;27(10):1548-61.PMID: 16330291 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of therapy with metformin plus pioglitazone in the treatment of patients with type 2 diabetes: a double-blind, placebo-controlled, clinical trial.

Kaku K.

Curr Med Res Opin. 2009 May;25(5):1111-9.PMID: 19309251 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.

Rosenstock J, Brazg R, Andryuk PJ, Lu K, Stein P; Sitagliptin Study 019 Group.

Clin Ther. 2006 Oct;28(10):1556-68.PMID: 17157112 [PubMed - indexed for MEDLINE]Related articles

Acarbose improves glycemic control in overweight type 2 diabetic patients insufficiently treated with metformin.

Phillips P, Karrasch J, Scott R, Wilson D, Moses R.

Diabetes Care. 2003 Feb;26(2):269-73.PMID: 12547847 [PubMed - indexed for MEDLINE]Related articlesFree article